Skip to main content

Veterinary Diagnostics Market Size to Surpass USD 14.48 billion by 2030, exhibiting a CAGR of 10.7%

As per the report by Fortune Business Insights, the global Veterinary Diagnostics Market size is projected to reach USD 14.48 billion in 2030, at a CAGR of 10.7% during the forecast period, 2023-2030

Veterinary Diagnostics Market

Veterinary Diagnostics Market (2023-2030)
Veterinary Diagnostics Market (2023-2030)

Pune, India, Aug. 31, 2023 (GLOBE NEWSWIRE) — The veterinary diagnostics market size was valued at USD 6.49 billion in 2022 and the market is anticipated to expand USD 14.48 billion by 2030, exhibiting a CAGR of 10.7% during forecast period. The rise is propelled by the increasing establishment of new diagnostic laboratories and rising pet insurance demand.

Fortune Business Insights™ provides this information in its research report, titled “Veterinary Diagnostics Market, 2023-2030”.


Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-diagnostics-market-101040


Key Industry Development:

May 2023 – IDEXX Laboratories partnered with Haychem Bangladesh Limited. The deal would provide access to IDEXX kits for monitoring flock health in Bangladesh.

Key Takeaways:

  • VeraSTAT-V and VeraSTAT were added to Randox Laboratories Ltd.’s point-of-care (POC) diagnostics portfolio for equine health in March 2022.
  • According to an article by the European Centre for Disease Prevention and Control published in 2022, there was an increase in the number of campylobacteriosis and salmonellosis cases in 2021 when compared to 2020.
  • Based on a 2023 Forbes article, about 66.0% of households in the United States, equivalent to 86.9 million homes, are pet owners.
  • Segmented by technique, the market is categorized into hematology, immunodiagnostics, molecular diagnostics, diagnostic imaging, clinical biochemistry, and other methods.


Discover the Leading Players Featured in the Report:

IDEXX Laboratories, Inc. (U.S.),Zoetis Services LLC (U.S.),Heska Corporation (U.S.),Thermo Fisher Scientific Inc. (U.S.),Avante Animal Health (U.S.),Virbac (France),Randox Laboratories Ltd. (U.K.),VCA Animal Hospitals (Mars, Incorporated) (U.S.),Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)


Report Scope & Segmentation

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR10.7%
2030 Value ProjectionUSD 14.48 billion
Base Year2022
Market Size in 2023USD 7.13 billion
Historical Data2019-2021
No. of Pages165
Segments coveredBy Product Type, Technique, Animal Type, End User, and Region


Browse Complete Report Details:  https://www.fortunebusinessinsights.com/industry-reports/veterinary-diagnostics-market-101040


Segmentation:

Reagents & Consumables Segment to Lead Owing to Soaring Frequency of Veterinary Tests

On the basis of product type, the market for veterinary diagnostics is subdivided into reagents & consumables and instruments. The reagents & consumables segment held a major market share in 2022 and is expected to record notable expansion over the analysis period. The surge is driven by increasing disposable income and growing prevalence of animal diseases.

Immunodiagnostics Segment to Hold Major Share Driven by Increasing Advanced Diagnostics Demand

By technique, the market is fragmented into hematology, immunodiagnostics, molecular diagnostics, diagnostic imaging, clinical biochemistry, and others. The immunodiagnostics segment accounted for a key share in the market in 2022 and is slated to register appreciable growth over the projected period. The expansion is impelled by the increasing product adoption for the diagnosis of animal diseases.

Veterinary Reference Laboratories Segment to Ace the Market Driven by High Data Reliability

Based on end user, the market for veterinary diagnostics is segregated into veterinary reference laboratories, veterinary hospitals & clinics, and others. The veterinary reference laboratories segment accounted for a dominating market share in 2022 impelled by the escalating significance of reference laboratories on account of high data reliability.

Companion Segment to Register Notable Growth Due to Increasing Spending on Pet Care

By animal type, the market for veterinary diagnostics is subdivided into companion and livestock. The companion segment accounted for the largest market share in 2022. The segment share is anticipated to rise at a considerable pace over the forecast period. The growth is driven by the soaring expenditure on pet care.

Based on geography, the market for veterinary diagnostics has been studied across North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa.

By Product Type

  • Instruments
  • Reagents & Consumables

By Technique

  • Hematology
  • Immunodiagnostics
  • Molecular Diagnostics
  • Diagnostic Imaging
  • Clinical Biochemistry
  • Others

By Animal Type

  • Livestock
  • Companion

By End User

  • Veterinary Hospitals & Clinics
  • Veterinary Reference Laboratories
  • Others

By Region

  • North America
  • EuropeAsia Pacific
  • Latin America
  • Middle East & Africa


Quick Buy – https://www.fortunebusinessinsights.com/checkout-page/101040

Driving factor:

Surge in Pet Ownership to Drive Market Expansion

One of the pivotal factors impelling the veterinary diagnostics market growth is the increasing trend of nuclear families and an upsurge in pet ownership. The product demand can also be attributed to the increased expenditure on pet care.
However, the dearth of skilled veterinary professionals for operating advanced diagnostic tools may hinder industry expansion to a considerable extent.

Regional insights:

North America to Emerge as Key Region Owing to Rising Employment in the Veterinary Sector

The North America market accounted for a dominant position in the global market in 2022. The veterinary diagnostics market share in the region is anticipated to record substantial growth over the estimated period. The rise is driven by the soaring employment in the veterinary sector and growing expenditure on pet care.

The Asia Pacific market is touted to expand at the fastest rate over the forecast period. The expansion is driven by the growing awareness pertaining to risks associated with zoonotic diseases in the region.

Competitive Landscape

Key Players Enter Strategic Partnerships to Increase Geographical Footprint

Major industry participants are focused on adopting a range of strategies for expanding the reach of their products. These strategies are also being adopted for increasing their geographical footprints. Some of these steps include partnerships, acquisitions, and the launch of new products, among others.


FAQs

How big is the Veterinary Diagnostics Market?

Veterinary Diagnostics Market size was USD 7.13 billion in 2023.

How fast is the Veterinary Diagnostics Market growing?

The Veterinary Diagnostics Market will exhibit a CAGR of 10.7% during the forecast period, 2023-2030.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/veterinary-diagnostics-market-101040

Related Links:

Veterinary Imaging Market Size, Share, Growth Industry Report

Companion Diagnostics Market Share, Size, Demand, and Forecast

Poultry Diagnostics Market Size, Share, Growth Industry Report

Animal Health Market Share, Size, Demand, and Forecast

Molecular Diagnostics Market Share, Size, Demand, and Forecast


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.